Boston Scientific (BSX) Translation and other — Quarterly & Annual

Screener

Translation and other at other companies

Teledyne TechnologiesTDY

-$25.8M—

Air Products and ChemicalsAPD

-$12.8M—

TerexTEX

-$3M+57.1%

CaterpillarCAT

$20M+219%

Wintrust FinancialWTFC

-$439K-136%

LivaNovaLIVN

-$6.45M-120%

Segments

By segment

Cardiovascular-$14M-147%

MedSurg-$5M-129%

Other financials

Income statement

Revenue$5.4B+7.5%

Gross profit$3.8B+12.4%

Operating income$1.2B+43.8%

Net income$907.0M+14.1%

EPS (diluted)$0.61+15.1%

Balance sheet

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

Market cap$69.19B-54.6%

P/E18.9×-42.3×

P/S3.3×-5.0×

Profitability

Gross margin69.9%+1.7pp

Operating margin19.8%+2.8pp

Net margin17.5%+4.0pp

FCF margin16.9%-0.3pp

Returns & leverage

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×